Free Trial

Sei Investments Co. Sells 11,842 Shares of Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background
Remove Ads

Sei Investments Co. trimmed its position in Maximus, Inc. (NYSE:MMS - Free Report) by 13.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 77,140 shares of the health services provider's stock after selling 11,842 shares during the quarter. Sei Investments Co. owned approximately 0.14% of Maximus worth $5,758,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. Nordea Investment Management AB acquired a new stake in Maximus during the 4th quarter worth about $4,618,000. Fort Washington Investment Advisors Inc. OH grew its position in Maximus by 39.1% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock valued at $22,132,000 after purchasing an additional 83,390 shares in the last quarter. IFP Advisors Inc grew its holdings in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Maximus in the fourth quarter worth $1,113,000. Finally, Legato Capital Management LLC raised its holdings in shares of Maximus by 33.9% during the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock worth $2,399,000 after acquiring an additional 8,138 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Stock Performance

Shares of MMS stock traded down $0.70 during trading on Thursday, reaching $70.33. The company had a trading volume of 504,184 shares, compared to its average volume of 538,198. The firm's 50 day simple moving average is $69.31 and its two-hundred day simple moving average is $77.41. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company has a market capitalization of $3.98 billion, a PE ratio of 15.12 and a beta of 0.71.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.71%. Maximus's dividend payout ratio is 25.81%.

Analyst Ratings Changes

Several brokerages have weighed in on MMS. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a research report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

Get Our Latest Stock Report on MMS

Insider Buying and Selling

In other news, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads